In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, talks about inflammatory biomarkers of mortality in women with stroke and rheumatoid arthritis, including whether stroke history modifies the effect of...
In this podcast, Georg Schett, MD, discusses the results and implications of his team’s recent study examining the tapering or stopping of medication in patients with rheumatoid arthritis who achieve stable...
Dr Winthrop talks about how vaccinations affect individuals with immunocompromised immune systems, the challenges associated with vaccination, and what rheumatologists should know about vaccines in 2020. ...
Dr Karpouzas discusses his research that evaluated whether β-2 glycoprotein 1 IgA antibodies can predict coronary plaque burden and progression, and whether the antibodies moderate the effect of...
What is the association between depression and subsequent risk of rheumatoid arthritis by serologic phenotype? In this Q&A, Jeffrey Sparks, MD, explains.
Dr Karpouzas talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as...
Vivian Bykerk, BSc, MD, from Hospital for Special Surgery, answers our questions on new research about the impact of HLA-DRB1 risk alleles on the clinical efficacy of 2 biologic agents for the...
Dr Karpouzas talks about his study that evaluated the influence of distinct domains of rheumatoid arthritis disease activity, functional limitation, mood disturbance, as well as RA-specific knowledge...
Vanessa Kronzer, MD, from the Mayo Clinic, answers our questions about her study that assessed the association between rheumatoid arthritis, asthma, passive smoke exposure, and more.
